Yorktown Management & Research CO Inc Abb Vie Inc. Transaction History

Yorktown Management & Research CO Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $445,005 - $489,897	-4,350 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $46,684 - $63,028	580 Added 15.38%	4,350 $466,000
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $18,900 - $22,182	220 Added 6.2%	3,770 $330,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $568,617 - $760,895	-7,750 Reduced 68.58%	3,550 $349,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $461,175 - $699,198	-7,150 Reduced 38.75%	11,300 $861,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $104,588 - $130,862	1,450 Added 8.53%	18,450 $1.63 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $217,979 - $268,828	-2,800 Reduced 14.14%	17,000 $1.57 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $177,820 - $197,680	2,000 Added 11.24%	19,800 $1.87 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $128,814 - $172,494	-1,400 Reduced 7.29%	17,800 $1.69 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $1.34 Million - $1.47 Million	15,000 Added 357.14%	19,200 $1.86 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $293,370 - $374,724	4,200	4,200 $373,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.